Table 2.
Percent changes in parameters in each group
| Parameters | n | Placebo | n | Theracurmin® | P-value |
|---|---|---|---|---|---|
| ΔBMI | 17 | −0.7±1.6 | 22 | 0.9±2.1 | 0.019 |
| ΔSBP | 17 | 1.4±17.6 | 22 | −1.3±15.9 | 0.618 |
| ΔDBP | 17 | 2.9±13.4 | 22 | 3.5±19.2 | 0.904 |
| ΔHbA1c | 17 | 0.0±2.6 | 22 | 0.4±3.0 | 0.631 |
| ΔBS | 16 | 14.5±37.5 | 21 | 5.8±25.7 | 0.407 |
| ΔTG | 17 | 14.5±55.3 | 22 | 9.2±44.0 | 0.743 |
| ΔLDL-C | 17 | 11.4±26.8 | 22 | 4.6±21.0 | 0.383 |
| ΔHDL-C | 17 | 2.0±16.3 | 22 | −2.8±13.0 | 0.317 |
| ΔUA | 16 | 2.3±18.6 | 22 | 2.4±9.2 | 0.970 |
| Δγ-GTP | 17 | −1.2±21.3 | 22 | −5.7±36.5 | 0.654 |
| ΔCre | 16 | 1.4±8.2 | 22 | 2.9±10.0 | 0.611 |
| ΔCRP | 16 | 11.1±98.3 | 22 | −12.5±51.9 | 0.344 |
| ΔSAA-LDL | 15 | 10.8±47.4 | 21 | −2.0±41.9 | 0.400 |
| ΔAT-LDL | 15 | 14.8±23.8 | 21 | −1.6±16.7 | 0.020 |
| ΔFEV1% | 16 | −3.6±6.0 | 21 | −1.9±6.1 | 0.411 |
Notes: Data presented as mean ± standard deviation unless stated otherwise. The percent change expresses the difference of baseline and after 6 months as a percentage of baseline. The percent change = ([after 6 months value − baseline value)/baseline value) ×100.
Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; BS, blood sugar; TG, triglyceride; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; UA, uric acid; γ-GTP, γ-glutamyl transpeptidase; Cre, creatinine; CRP, C-reactive protein; SAA-LDL, serum amyloid A-LDL; AT-LDL, α1-antitrypsin-LDL; FEV1%, percent forced expiratory volume in 1 second.